Press Releases
M-Life™ Toxicity Predictions for Repurposed COVID-19 Drugs
NASHVILLE, TENNESSEE – M-LIFE™ has predicted the toxicity profiles across multiple organ systems for a variety of prospective re-purposed COVID-19 drugs. The objective for identifying prospective repurposed drugs is to find on-market therapeutics having the potential...
M-Life™ Drugs on Market as Repurposing Prospects for the Treatment of COVID-19
M-LIFE™, a biotech and life sciences company, has identified six marketed drugs suitable for repurposing as possible therapies for COVID-19. These drugs have not been previously indicated via the mainstream media. Additionally, these newly identified prospects...